• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Effect of triflusal and other salicylic acid derivatives on cyclic AMP levels in rat platelets.

作者信息

García-Rafanell J, Ramis J, Gomez L, Forn J

出版信息

Arch Int Pharmacodyn Ther. 1986 Nov;284(1):155-65.

PMID:3030206
Abstract

The effect of triflusal, acetylsalicylic acid (ASA), and of their principal metabolites 2-hydroxy-4-trifluoromethylbenzoic acid (HTB) and salicylic acid (SA), alone or combined with dypiridamole (DIP) and/or PGE1 on cyclic AMP levels in washed rat platelets (37 degrees C, 4 min), has been determined. DIP at 0.1 mM increased cyclic AMP levels by 25%. The effect of triflusal and HTB was significant at therapeutic concentrations of triflusal (1 mM: 36% increase) and HTB (0.5 mM: 37% increase). The effect of HTB was always greater than that of triflusal. ASA, at 1 mM and 5 mM, alone or combined with PGE1 was without effect. When 1 mM triflusal was combined with 0.1 mM DIP an increased effect was obtained (95%). ASA, at the highest concentration tested (5 mM), did not modify the DIP-induced increase of cyclic AMP levels.

摘要

相似文献

1
Effect of triflusal and other salicylic acid derivatives on cyclic AMP levels in rat platelets.
Arch Int Pharmacodyn Ther. 1986 Nov;284(1):155-65.
2
Effect of triflusal and acetylsalicylic acid on platelet aggregation in human whole blood: influence of red blood cells and leukocytes.曲氟尿苷和乙酰水杨酸对人全血中血小板聚集的影响:红细胞和白细胞的作用
Methods Find Exp Clin Pharmacol. 1988 Jun;10(6):363-7.
3
Inhibition of cyclooxygenase-2 expression by 4-trifluoromethyl derivatives of salicylate, triflusal, and its deacetylated metabolite, 2-hydroxy-4-trifluoromethylbenzoic acid.水杨酸的4-三氟甲基衍生物、曲氟尿苷及其脱乙酰代谢产物2-羟基-4-三氟甲基苯甲酸对环氧合酶-2表达的抑制作用。
Mol Pharmacol. 1999 Apr;55(4):753-60.
4
Protective effect of triflusal and its main metabolite HTB in an in vitro model of anoxia-reoxygenation in rat brain slices: comparison with acetylsalicylic and salicylic acids.曲氟尿苷及其主要代谢产物HTB在大鼠脑片缺氧-复氧体外模型中的保护作用:与乙酰水杨酸和水杨酸的比较。
Naunyn Schmiedebergs Arch Pharmacol. 2005 Jan;371(1):81-8. doi: 10.1007/s00210-004-1001-y. Epub 2004 Dec 16.
5
4-trifluoromethyl derivatives of salicylate, triflusal and its main metabolite 2-hydroxy-4-trifluoromethylbenzoic acid, are potent inhibitors of nuclear factor kappaB activation.水杨酸酯的4-三氟甲基衍生物、曲氟尿苷及其主要代谢物2-羟基-4-三氟甲基苯甲酸是核因子κB激活的有效抑制剂。
Br J Pharmacol. 1999 Mar;126(6):1359-66. doi: 10.1038/sj.bjp.0702441.
6
Effects and interaction studies of triflusal and other salicylic derivatives on cyclooxygenase in rats.
Prostaglandins Leukot Essent Fatty Acids. 1988 Feb;31(2):83-9. doi: 10.1016/0952-3278(88)90080-4.
7
Platelet antiaggregatory effect of triflusal in human whole blood.曲氟尿苷在人全血中的血小板抗聚集作用。
Methods Find Exp Clin Pharmacol. 1988 Apr;10(4):273-7.
8
Effects of triflusal and its main metabolite HTB on platelet interaction with subendothelium in healthy volunteers.曲氟尿苷及其主要代谢产物HTB对健康志愿者血小板与内皮下层相互作用的影响。
Eur J Clin Pharmacol. 1995;47(6):497-502. doi: 10.1007/BF00193701.
9
Effect of adenyl-cyclase activators, phosphodiesterase inhibitors and pyridoxal-5-phosphate on platelet aggregation and adenosine-3'-5'-cyclic monophosphate accumulation.腺苷酸环化酶激活剂、磷酸二酯酶抑制剂及磷酸吡哆醛-5-磷酸对血小板聚集和3'-5'-环磷酸腺苷积聚的影响
Thromb Haemost. 1984 Oct 31;52(2):205-9.
10
Inhibition of cardiac hypertrophy by triflusal (4-trifluoromethyl derivative of salicylate) and its active metabolite.曲氟尿苷(水杨酸的4-三氟甲基衍生物)及其活性代谢产物对心肌肥大的抑制作用。
Mol Pharmacol. 2006 Apr;69(4):1174-81. doi: 10.1124/mol.105.016345. Epub 2006 Jan 18.

引用本文的文献

1
Effect of Triflusal on Primary Vascular Dysregulation Compared with Aspirin: A Double-Blind, Randomized, Crossover Trial.
Yonsei Med J. 2015 Sep;56(5):1227-34. doi: 10.3349/ymj.2015.56.5.1227.
2
Gastrointestinal safety of triflusal solution in healthy volunteers: a proof of concept endoscopic study.三氟柳溶液在健康志愿者中的胃肠道安全性:概念验证内镜研究。
Eur J Clin Pharmacol. 2011 Jul;67(7):663-9. doi: 10.1007/s00228-011-1004-9. Epub 2011 Feb 16.
3
Triflusal: a review of its use in cerebral infarction and myocardial infarction, and as thromboprophylaxis in atrial fibrillation.曲氟尿苷:关于其在脑梗死和心肌梗死中的应用以及作为心房颤动血栓预防药物的综述。
Drugs. 2006;66(5):671-92. doi: 10.2165/00003495-200666050-00009.
4
Triflusal.
Drugs. 1998 Jun;55(6):823-33; discussion 834-5. doi: 10.2165/00003495-199855060-00011.
5
Effects of triflusal and its main metabolite HTB on platelet interaction with subendothelium in healthy volunteers.曲氟尿苷及其主要代谢产物HTB对健康志愿者血小板与内皮下层相互作用的影响。
Eur J Clin Pharmacol. 1995;47(6):497-502. doi: 10.1007/BF00193701.
6
Pharmacokinetics of triflusal and its main metabolite HTB in healthy subjects following a single oral dose.单次口服给药后,健康受试者中曲氟尿苷及其主要代谢物HTB的药代动力学。
Eur J Drug Metab Pharmacokinet. 1991 Oct-Dec;16(4):269-73. doi: 10.1007/BF03189971.
7
Pharmacokinetics of triflusal and its main metabolite in rats and dogs.曲氟尿苷及其主要代谢物在大鼠和犬体内的药代动力学
Eur J Drug Metab Pharmacokinet. 1991 Oct-Dec;16(4):261-8. doi: 10.1007/BF03189970.